This literature review synthesizes findings from primary research studies on CDC25 phosphatase expression and localization in esophageal squamous cell carcinoma (ESCC). CDC25 proteins regulate cell cycle progression, and their overexpression has been implicated in multiple cancers, particularly ESCC—the fourth leading cause of cancer deaths in China. The review evaluates evidence linking CDC25 expression levels and subcellular localization to ESCC pathogenesis and prognosis, identifies gaps in the literature regarding biochemical dysfunction and enzymatic activity, and proposes future research directions, including functional inhibition studies and therapeutic targeting of CDC25.
CDC25 is a phosphatase involved in cell cycle progression. CDC25B promotes the G2 to M transition by dephosphorylating substrates, particularly the CDK1/cyclin B complex. CDC25B has been found by several studies to be overexpressed in several human cancers, including esophageal squamous cell carcinoma (ESCC) and vulvar squamous cell carcinoma (Wang et al., 2010, p. 234). CDC25A and CDC25C also promote cell cycle progression, but CDC25A has been more closely associated with the G1/S transition than the G2/M transition (Nishioka et al., 2001, p. 412).
ESCC is among the most lethal cancers, especially in China where it is the fourth leading cause of cancer deaths (Dong et al., 2010, p. 82). Furthermore, CDC25 dysfunction has been associated with clinical prognosis (Nishioka et al., 2001, p. 412). The likely reasons for this are an increase in CDC25 catalytic activity in cancer cells, an increase in expression levels of CDC25 protein or CDC25 mRNA, or a change in subcellular localization (Wang et al., 2010, p. 234).
This review focuses on the literature that has studied changes in CDC25 protein expression and subcellular localization in normal and cancer cells, as well as changes in cdc25 mRNA expression in normal and cancer cells. This review also suggests topics for future studies of the involvement of CDC25 in ESCC. Additional studies are needed in order to further elucidate the molecular basis of tumorigenesis and cancer progression in this disease.
In searching databases for studies to include in this review, terminology and specific databases were carefully chosen. The databases selected were Academic OneFile and Medline, chosen due to their likelihood to contain a wide variety of results including studies involving different techniques. These databases were also selected for their ease of searching, with a large number of results that could be narrowed using additional terminology and date of publication criteria. A final criterion was their ease of access to full-text articles.
Parameters used to narrow search results included year of publication and the addition of narrowing terminology. The keywords chosen for initial searches were "cdc25 squamous cell carcinoma," with the additional term "esophageal" used to narrow search results further.
A search of the Academic OneFile database for the keywords "squamous cell carcinoma cdc25" yielded two results, both of which were used in the current review. A search of the Medline database using the same keywords yielded 27 results, which were narrowed to nine results with the addition of the keyword "esophageal." The two results from both databases were chosen for review, as were three additional results from Medline that contained comprehensive studies published within the past ten years.
Several features of the search results are notable. First, the majority of results were primary research studies focused on the molecular aspects of ESCC. The results were dominated by studies of protein and mRNA expression, with few epidemiological and clinical studies. This is likely due to inclusion of the term "cdc25" in the search criteria.
The second notable feature is the lack of biochemistry studies. Only two of 27 Medline results contained data with biochemical or enzymological information. A third feature of the search results is that most of them included data on or references to ESCC, even before the search results were narrowed by inclusion of the term "esophageal." This result suggests that many studies have implicated esophageal carcinoma in particular with squamous cell carcinomas involving CDC25.
Another limitation of the literature is that few studies researched why ESCC is so much more common in Northern China compared to the rest of China or other countries. Some evidence indicates tobacco and alcohol use as predisposing factors for ESCC (Shou et al., 2008, p. 19), but further studies are needed to explore this important question.
A final notable feature of the results is that they indicate widespread agreement on the implication of CDC25 protein and mRNA expression levels and subcellular localization in ESCC. Few studies of CDC25 enzymatic function or dysfunction appeared in the search results.
The results of the literature search highlight the importance of the problem of ESCC for two main reasons. First, the results suggest that a substantial amount of research has been conducted into this major clinical problem, the fourth leading cause of cancer deaths in China and a highly lethal form of carcinoma (Dong et al., 2010, p. 82). Second, the results suggest that ESCC could be a good system for studying the molecular basis of cell cycle progression. This is because ESCC involves dysfunction or dysregulation of CDC25, a key molecule involved in regulating the cell cycle in normal cells.
"Overexpression correlation with prognosis"
"Lack of enzymatic and kinetic studies"
"Functional inhibition and causal mechanism proof"
You’re 66% through this paper. Sign up to read the remaining 3 sections.
Sign Up Now — Instant Access Already a member? Log inAlways verify citation format against your institution’s current style guide requirements.